DrugDashboards

Dobutamine Hydrochloride

Dobutamine Hydrochloride · DOBUTAMINE HYDROCHLORIDE 100 mg/100mL · Injection · Intravenous · HF Acquisition Co LLC, DBA HealthFirst

NDC 51662-1566-01 · 250 mL in 1 BAG · NDA · View full market →

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately. It is in shortage right now.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Medicare Part B (ASP)

Payment limit per 250 MG
$7.691
HCPCS J1250 · Jul 1, 2026 quarter · typically ASP + 6%

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
NDA020255
TE code
AP
Approval date
Oct 19, 1993
Patents / exclusivity
None on file

Shortage history

  • In shortage now — Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 100 mg/100 mL (NDC 0338-1073-02)Nov 6, 2017
    month 106 — 5× the typical 20-month injectable shortage · model puts 23% odds it resolves within 6 months
  • In shortage now — Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 200 mg/100 mL (NDC 0338-1075-02)Nov 6, 2017
    month 106 — 5× the typical 20-month injectable shortage · model puts 23% odds it resolves within 6 months
  • In shortage now — Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 400 mg/100 mL (NDC 0338-1077-02)Nov 6, 2017
    month 106 — 5× the typical 20-month injectable shortage · model puts 23% odds it resolves within 6 months

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Dobutamine Hydrochloride (Injection)

LabelerStrengthFirst seenLast seen
Baxter Healthcare CorporationDOBUTAMINE HYDROCHLORIDE 100 mg/100mLJul 15, 2026Sep 2, 2026
Baxter Healthcare CorporationDOBUTAMINE HYDROCHLORIDE 200 mg/100mLJul 15, 2026Sep 2, 2026
Baxter Healthcare CorporationDOBUTAMINE HYDROCHLORIDE 400 mg/100mLJul 15, 2026Sep 2, 2026
HF Acquisition Co LLC, DBA HealthFirstDOBUTAMINE HYDROCHLORIDE 100 mg/100mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Dobutamine Hydrochloride — NDC 51662-1566-01," retrieved September 3, 2026, https://drugdashboards.com/drug/51662156601.

Free to cite with attribution — see how the data is put together.